|midatech pharma plc||1.19||0.3||9506||37|
|midatech pharma share price||0.79||0.8||8900||16|
|midatech pharma stock||1.15||0.2||5878||57|
|midatech pharma share chat||1.34||0.5||2638||72|
|midatech pharma news||0.97||0.9||5092||54|
|midatech pharma plc stock||0.76||0.7||3737||22|
|midatech pharma stocktwits||0.15||0.3||6237||25|
|midatech pharma adr||1.69||0.4||6560||21|
|midatech pharma cardiff||1.65||1||5795||80|
|midatech pharma wales ltd||1.17||0.5||2881||18|
|midatech pharma wales limited||0.97||0.2||9501||42|
|midatech pharma stock forecast||1.98||0.2||3048||90|
|midatech pharma plc-adr||0.71||0.7||7142||28|
|midatech pharma plc mtp||1.27||0.4||7468||42|
Midatech Pharma is building an innovative portfolio of first-to-sustained release treatments across multiple therapeutic areas with the most pressing unmet patient need. At Midatech Pharma we recognise the power of partnership in developing and progressing the next generation of patient orientated medicines.Where is midmidatech located?
Midatech's headquarters and R&D facility are in Cardiff, UK. Midatech Pharma is interested in hearing from potential collaborators from all pursuits.What is the PE (Price/b ratio) of Midatech Pharma?
Midatech Pharma has a P/B Ratio of 1.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. How has Midatech Pharma's stock price been impacted by Coronavirus (COVID-19)?Who owns mitmidatech pharma's stock?
Midatech Pharma's stock is owned by a number of institutional and retail investors. Top institutional investors include Lombard Odier Asset Management USA Corp (2.33%), Renaissance Technologies LLC (1.73%) and Morgan Stanley (1.27%).